1. Home
  2. PEW vs MAIA Comparison

PEW vs MAIA Comparison

Compare PEW & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GrabAGun Digital Holdings Inc.

PEW

GrabAGun Digital Holdings Inc.

HOLD

Current Price

$2.96

Market Cap

72.6M

ML Signal

HOLD

Logo MAIA Biotechnology Inc.

MAIA

MAIA Biotechnology Inc.

HOLD

Current Price

$1.44

Market Cap

79.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PEW
MAIA
Founded
2007
2018
Country
United States
United States
Employees
50
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.6M
79.0M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
PEW
MAIA
Price
$2.96
$1.44
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.75
N/A
AVG Volume (30 Days)
835.1K
582.0K
Earning Date
05-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
33.33
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$5.25
N/A
Revenue Next Year
$7.96
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.25
$0.87
52 Week High
$10.04
$3.19

Technical Indicators

Market Signals
Indicator
PEW
MAIA
Relative Strength Index (RSI) 60.74 56.15
Support Level $2.70 $1.24
Resistance Level $3.27 $1.46
Average True Range (ATR) 0.19 0.08
MACD 0.09 0.00
Stochastic Oscillator 73.51 68.42

Price Performance

Historical Comparison
PEW
MAIA

About PEW GrabAGun Digital Holdings Inc.

GrabAGun Digital Holdings Inc is a multi-brand eCommerce retailer of firearms, ammunition and related accessories. The Company's firearm products are ordered and paid for by customers online through the Company's eCommerce site and mobile app and are delivered to them on-premises through their choice of federal firearm licensed dealers nationwide. The Company's network of localized firearm dealers perform background checks on firearms purchasers and complete sales forms as mandated by federal and state firearm regulations.

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of targeted immunotherapies for cancer, with an initial focus on non-small cell lung cancer (NSCLC), which represents the majority of lung cancer cases. Its asset, ateganosine (THIO, also known as 6-thio-dG or 6-thio-deoxyguanosine), is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The treatment approach involves administering THIO followed by the immune checkpoint inhibitor Libtayo (cemiplimab), which is manufactured and commercialized by Regeneron.

Share on Social Networks: